5 GLP-1RAs, as exemplified by liraglutide and semaglutide, exhibit pronounced cardiovascular protective effects
For patients with chronic kidney disease, heart failure, or established atherosclerotic cardiovascular disease, substituting a sodium-glucose cotransporter 2 (SGLT2) inhibitor may be preferred
Roughly 45% of large employers now include at least one anti-obesity medication on their formulary, up from about 25% in 2023
Sahay, Emrah Gecili, Andrew T
If youre weighing headline offers, look for structured deals that reward steady play rather than single bursts
Reach out to local Ozempic providers near you, and take the first step in transforming your health